SEC Form 4 · accession 0000919574-18-008210
Molecular Templates, Inc. · MTEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Bruce Kovner
Director
CAXTON CORP
Director
CDK ASSOCIATES, L.L.C.
Director
Scott D Morenstein
Director
Period of report
Dec 26, 2018
Accepted (ET)
Dec 28, 2018 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001183765
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 26, 2018 | P | 25,000 | $3.45 | A | 1,584,241 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by CDK Associates, L.L.C. and may be deemed to be beneficially owned by (i) Scott Morenstein, a Managing Director of Caxton Alternative Management LP, the investment manager of CDK Associates, L.L.C., (ii) Caxton Corporation, the manager of CDK Associates, LLC and (iii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Scott Morenstein serves as a director of the Issuer. Caxton Corporation, Bruce Kovner and CDK Associates, L.L.C. may be considered directors by deputization due to their affiliation with Scott Morenstein. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.